Search Results - "Gorol, Jaroslaw"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    TCT-489 Complete percutaneous revascularization in ischemic heart failure improves survival – report from the COMMIT-HF registry by Pyka, Lukasz, Hawranek, Michal, Tajstra, Mateusz, Gorol, Jarosław, Kurek, Anna, Krajewski, Adam, Lekston, Andrzej, Gierlotka, Marek, Gasior, Mariusz

    “…Complete revascularization Incomplete revascularization p Sex 157M vs 31F 130M vs 29F 0,66 Age 63,7±10,6 66,5±11,2 0,01 Mean EF [%] 28,5±5,6 27,3±5,4 0,13 NYHA…”
    Get full text
    Journal Article
  3. 3

    Radiation therapy in patients with cardiac implantable electronic devices by Niedziela, Jacek T, Blamek, Sławomir, Gadula-Gacek, Elżbieta, Gorol, Jarosław, Kurek, Anna, Witek, Mateusz, Wojtaszczyk, Adam, Plaza, Przemysław, Miszczyk, Leszek, Gąsior, Mariusz, Tajstra, Mateusz

    Published in Kardiologia polska (25-02-2021)
    “…The number of patients with cardiac implantable electronic devices (CIEDs) treated with radiation therapy (RT) as an oncological treatment is expected to…”
    Get full text
    Journal Article
  4. 4

    Comparison of outcomes in patients undergoing rotational atherectomy after unsuccessful coronary angioplasty versus elective rotational atherectomy by Gorol, Jaroslaw, Tajstra, Mateusz, Hudzik, Bartosz, Lekston, Andrzej, Gąsior, Mariusz

    Published in Postępy w kardiologii interwencyjnej (01-01-2018)
    “…Revascularization of patients with heavily calcified coronary arteries can be a challenge for interventional cardiologists. The procedural success rate in…”
    Get full text
    Journal Article
  5. 5

    Complete percutaneous revascularisation feasibility in ischaemic heart failure is related to improved outcomes: insights from the COMMIT-HF registry by Pyka, Łukasz, Hawranek, Michał, Tajstra, Mateusz, Gorol, Jarosław, Lekston, Andrzej, Gąsior, Mariusz

    Published in Kardiologia polska (01-01-2017)
    “…Heart failure (HF) is a major cause of death in cardiovascular disease. In a post-STICH landscape, we lack data on the role of percutaneous coronary…”
    Get full text
    Journal Article
  6. 6

    COnteMporary Modalities In Treatment of Heart Failure: a report from the COMMIT-HF registry by Gąsior, Mariusz, Pyka, Łukasz, Gorol, Jarosław, Hawranek, Michał, Tajstra, Mateusz, Słonka, Grzegorz, Kurek, Anna, Krajewski, Adam, Rozentryt, Piotr, Gierlotka, Marek, Lekston, Andrzej, Zembala, Marian, Poloński, Lech

    Published in Kardiologia polska (01-01-2016)
    “…Heart failure (HF) has become a global health problem and is a significant burden for health-care systems worldwide. It is reported as the reason for 1-4% of…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Platelet-to-lymphocyte ratio is a marker of poor prognosis in patients with diabetes mellitus and ST-elevation myocardial infarction by Hudzik, Bartosz, Szkodzinski, Janusz, Gorol, Jaroslaw, Niedziela, Jacek, Lekston, Andrzej, Gasior, Mariusz, Polonski, Lech

    Published in Biomarkers in medicine (01-03-2015)
    “…Platelet-to-lymphocyte ratio (PLR) has emerged as a strong marker of worse outcomes. We determined the association between PLR and clinical outcomes in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Prognostic significance of mean platelet volume in diabetic patients with ST-elevation myocardial infarction by Lekston, Andrzej, Hudzik, Bartosz, Hawranek, Michal, Szkodzinski, Janusz, Gorol, Jaroslaw, Wilczek, Krzysztof, Gasior, Mariusz, Polonski, Lech

    Published in Journal of diabetes and its complications (01-09-2014)
    “…Abstract Purpose Mean platelet volume (MPV) is a universally available parameter with routine blood counts. It has been linked to many cardiovascular risk…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15